Please provide your email address to receive an email when new articles are posted on . Published results showed lumbar microdiscectomy with a bone-anchored annular closure device for treatment of ...

The MarketWatch News Department was not involved in the creation of this content. BOSTON, Oct. 24, 2025 /PRNewswire/ -- Intrinsic Therapeutics, Inc., the makers of the Barricaid(R) Annular Closure ...

The American Medical Association released its CPT 2026 code set, which includes the new CPT code 63032 fr bone-anchored annular closure, Intrinsic Therapeutics said Oct. 24. The new add-on CPT code ...

PR Newswire BOSTON, March 4, 2026 BOSTON, March 4, 2026 /PRNewswire/ -- Intrinsic Therapeutics, Inc. has introduced the Barricaid ® Narrow Anchor, the next generation of its FDA PMA-approved Barricaid ...

Discectomies are one of the highest-volume spine procedures performed in an ASC. With more than 400,000 discectomies annually — a number that exceeds spinal fusions — discectomies can be a major ...

Discectomy is a common outpatient spinal procedure, but for patients with large annular defects (>5mm), outcomes can be unpredictable and sometimes devastating. In a session at Becker’s 22nd Spine, ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Published results showed a decrease in the use of ...

BOSTON, June 19, 2025 /PRNewswire/ -- Intrinsic Therapeutics, a medical technology company committed to redefining the standard of care for lumbar discectomy patients with large annular defects by ...

“Advancing OctaSeal into FDA review represents a significant inflection point, not just for Spinol, but for a market that has been underserved for decades. With only one competitor in a ...

BOSTON, Oct. 24, 2025 /PRNewswire/ -- Intrinsic Therapeutics, Inc., the makers of the Barricaid® Annular Closure Device, announced today that the American Medical Association (AMA) has published a new ...